Dr Rogier Hopstaken | A Simple Point-of-Care Test to Combat Antibiotic Resistance

Feb 7, 2024 | health and medicine

About this episode

While antibiotics are an essential tool for treating disease, their effectiveness in preventing severe illness and death is under threat. Antibiotic resistance is now one of the biggest dangers to global health. When a bacterial infection is treated with antibiotics, certain bacteria in a patient may hold genetic mutations that allow them to evade destruction. These resistant bacteria can become more severe and spread further, requiring stronger antibiotics or potentially leading to the patient’s death. Around 5 million deaths were related to antibiotic resistance in 2019 alone, and cases are predicted to rise. Read More

Original Article Reference

Summary of the papers:

Implementing point-of-care CRP testing for better diagnosis of acute respiratory infections, doi.org/10.3399/bjgp22X718517

Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial, doi.org/10.1136/bmj.n2198

Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial, doi.org/10.1370/afm.1090

Effect of point of care testing for C-reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial, doi.org/10.1136/bmj.b1374

Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection, PMID: 12830562; PMCID: PMC1314594

Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care, doi.org/10.3389/fmed.2023.1166742

Contact

For further information, you can connect with Dr Rogier Hopstaken at rogier.hopstaken@maastrichtuniversity.nl

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Are you ready to increase the impact of your research?

More episodes

Dr. Ze (Mia) Zhu | The Promise of Just-in-Time Adaptive Interventions in Organizational Settings

The emotional state and job performance of an employee can greatly fluctuate over minutes, hours and days. Towards...

Dr Claudia Manzi – Dr Eleonora Crapolicchio | How Companies Can Retain Young Workers

Younger workers will have a far higher number of jobs throughout their careers, compared to previous generations....

Dr Martin Haesemeyer | A Deep-learning Framework that Links Brain Activity with Behavior

Neuroscientists have been trying to uncover the relationships between brain activity and behavior for decades....

Dr Mariëlle Stel – Janina Eggers – Dr Wladimir Alonso | Promoting a Plant-based Transition to Reduce Zoonotic Diseases

Zoonotic diseases are infections that are transmitted from animals to humans and vice versa. For example, COVID-19 has...

Professor Amy MacNeill | Combining a Virus and Immunotherapy to Treat Cancer in Dogs

Soft-tissue sarcomas are a common type of tumor found in dogs, which can arise in connective, muscle, or nervous...

Dr Mats Ljungman | KLIPP: Targeting Cancer with CRISPR

Cancer treatments are designed to kill cells within a tumor, but they often affect healthy tissues, leading to serious...

Stay Up To Date With SciTube

Subscribe to receive our latest videos straight to your mailbox

 

Follow Us On: